These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17103075)
61. Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases. Volk AM; Fritzmann J; Reissfelder C; Weber GF; Weitz J; Rahbari NN BMC Cancer; 2016 Feb; 16():84. PubMed ID: 26864935 [TBL] [Abstract][Full Text] [Related]
62. [A case of unresectable multiple liver metastases of colorectal cancer in which ALTA(ZION), used to control internal hemorrhoidal bleeding, enabled administration of bevacizumab]. Kato K; Otsuka K; Kato N; Itabashi T; Akiyama Y; Wakabayashi G Gan To Kagaku Ryoho; 2013 Nov; 40(11):1553-5. PubMed ID: 24231714 [TBL] [Abstract][Full Text] [Related]
63. [Four cases of bevacizumab-related gastrointestinal perforation]. Uchino T; Mishima H; Kimura K; Mori D; Ando K; Nagata H; Kondo R; Kosaka K; Ohashi N; Ito N; Arikawa T; Miyachi M; Suzumura K; Sano T; Nonami T Gan To Kagaku Ryoho; 2014 Nov; 41(12):2506-8. PubMed ID: 25731572 [TBL] [Abstract][Full Text] [Related]
64. Diaphragmatic rupture, a new complication of Bevacizumab. Lacaze L; Scotté M Eur J Surg Oncol; 2012 Nov; 38(11):1079-81. PubMed ID: 22818843 [TBL] [Abstract][Full Text] [Related]
65. Bevacizumab-related surgical site complication despite primary tumor resection in colorectal cancer patients. Bège T; Lelong B; Viret F; Turrini O; Guiramand J; Topart D; Moureau-Zabotto L; Giovannini M; Gonçalves A; Delpero JR Ann Surg Oncol; 2009 Apr; 16(4):856-60. PubMed ID: 19156464 [TBL] [Abstract][Full Text] [Related]
66. A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab. Baxter NN; Fischer HD; Richardson DP; Urbach DR; Bell CM; Rochon P; Brade A; Earle CC Dis Colon Rectum; 2018 Mar; 61(3):306-313. PubMed ID: 29420426 [TBL] [Abstract][Full Text] [Related]
67. Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancer. Utsumi H; Honma Y; Nagashima K; Iwasa S; Takashima A; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Kishi Y; Nara S; Esaki M; Shimada K Anticancer Res; 2015 Apr; 35(4):2255-61. PubMed ID: 25862887 [TBL] [Abstract][Full Text] [Related]
68. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. Ellis LM; Curley SA; Grothey A J Clin Oncol; 2005 Aug; 23(22):4853-5. PubMed ID: 16051943 [No Abstract] [Full Text] [Related]
69. Bevacizumab Does Not Inhibit the Formation of Liver Vessels and Liver Regeneration Following Major Hepatectomy: A Large Animal Model Study. Troup O; Skalicky A; Vistejnova L; Klein P; Maleckova A; Florova B; Malkus T; Molacek J; Treska V; Kriz M; Zeman J; Skalicky T In Vivo; 2022; 36(3):1083-1094. PubMed ID: 35478151 [TBL] [Abstract][Full Text] [Related]
70. In search of the black sheep: is it bevacizumab or extended chemotherapy? Vauthey JN; Zorzi D Ann Surg Oncol; 2009 Jun; 16(6):1463-4. PubMed ID: 19357926 [No Abstract] [Full Text] [Related]
71. [A case of glomerulopathy associated with the vascular endothelial growth factor inhibitor bevacizumab]. Haruhara K; Tsuboi N; Nakao M; Koike K; Fukui A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T Nihon Jinzo Gakkai Shi; 2014; 56(5):600-5. PubMed ID: 25130032 [TBL] [Abstract][Full Text] [Related]
72. Histological and immediate postoperative outcome after preoperative cetuximab: case-matched control study. Pessaux P; Marzano E; Casnedi S; Bachellier P; Jaeck D; Chenard MP World J Surg; 2010 Nov; 34(11):2765-72. PubMed ID: 20652697 [TBL] [Abstract][Full Text] [Related]
74. Histological and immediate postoperative outcome after preoperative cetuximab: case-matched control study. Spiliotis J; Zoras O World J Surg; 2011 May; 35(5):1153-4. PubMed ID: 21184075 [No Abstract] [Full Text] [Related]
75. Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study. Tsai HT; Marshall JL; Weiss SR; Huang CY; Warren JL; Freedman AN; Fu AZ; Sansbury LB; Potosky AL Ann Oncol; 2013 Jun; 24(6):1574-9. PubMed ID: 23429865 [TBL] [Abstract][Full Text] [Related]
76. Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report. Leal T; Robins HI Cancer Chemother Pharmacol; 2010 Jan; 65(2):399-401. PubMed ID: 19756604 [TBL] [Abstract][Full Text] [Related]
77. Thirty-minutes infusion rate is safe enough for bevacizumab; no need for initial prolong infusion. Yanmaz MT; Guner SI; Satılmıs B; Akyol H; Aydın MA Med Oncol; 2014 Nov; 31(11):276. PubMed ID: 25294426 [TBL] [Abstract][Full Text] [Related]
78. [Perioperative Steroid Administration for Colorectal Cancer with Synchronous Unresectable Hepatic Metastases]. Ohira G; Miyauchi H; Narushima K; Kagaya A; Muto Y; Saito H; Matsubara H Gan To Kagaku Ryoho; 2015 Nov; 42(12):1515-7. PubMed ID: 26805081 [TBL] [Abstract][Full Text] [Related]
79. [Prophylaxis of hepatic insufficiency after major hepatic resections]. Khoronenko VÉ; Donskova IuS; Baskakov DS; Drozhzhina OV; Sidorov DV; Lozhkin MV; Petrov LO; Nemtsova ER; Iakubovskaia RI Anesteziol Reanimatol; 2014; 59(4):33-8. PubMed ID: 25549484 [TBL] [Abstract][Full Text] [Related]
80. Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer. Adenis A; Vanseymortier L; Foissey D; Colombel JF Gut; 2007 May; 56(5):734. PubMed ID: 17440191 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]